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A stabilization of both the precursor and the mature/31 integrin subunit was observed in metabohcally labeled human skin fibroblasts and Molt-4 
T lymphocytes upon addition of protein synthesis inhibitors or by ATP depletion. Differential effects of protem synthesis inhibitors are reported 
since the slow degradation of the mature pl subunit was sensitive to cycloheximtde but not to puromycin. We also show that the half-hfe of the 
mature subunit was not dependent on intracellular lysosomal degradation or on ubiquitmation suggesting that VLA turn-over occurs at the cell 
surface and might involve proteins or proteases wtth short half-life. 
VLA degradation; Protein synthesis inhibitor; ATP depletion; Ubiquitin; Lysosome 
1. INTRODUCTION 
Integrins are non-covalently linked transmembrane 
heterodimers composed of a single /I subunit which can 
associate with several different a subunits. At present, 
at least fourteen c1 and eight p subunits have been de- 
scribed which combine to form functionally distinct cell 
surface molecules [I]. 
In an attempt to better characterize early events in the 
biosynthesis, the processing and the turn-over of VLA 
or pl integrins, we showed previously that immature 
(endo-H sensitive) CI and PI subunits could be coprecip- 
itated and that in different cell types the pl precursor 
was proteolytically degraded in a pre-Golgi compart- 
ment, sensitive to temperature and phenanthroline [2,3]. 
In the present study, we report that cycloheximide 
and other protein synthesis inhibitors inhibit the rapid 
degradation of the Bl precursor, while the slow degra- 
dation of mature subunit is only inhibited by cyclo- 
heximide but not by puromycin. 
We also show that the slow turn-over of mature VLA- 
receptors is apparently not sensitive to lysosomotropic 
agents or to ubiquitination but can be prolonged by 
ATP perturberssuggesting that processing at the cell 
surface is the main fate of these receptors. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Endo-/3-N-acetylglycosaminidase-H (endo-H). leupeptin, soybean 
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trypsin Inhibitor (SBTI), phenylmethylsulfonylfluoride (PMSF), hy- 
gromycin B and I-chloro-3-tosylamido-4-phenyl-2-butanone (TPCK) 
were purchased from Boehringer. Antipam. pepstatin. and one batch 
cycloheximide were supplied by Sigma. Sepharose CNBr was from 
Pharmacia, Triton X-100 and 6-aminocaproic acid (6-AHA) from 
Janssen Chemica, NaDodSO, (SDS) from Serva, deoxycholate 
(DOC), NH&I, trichloroacettc acid (TCA), NaF and NaN, from 
Merck. cyclohextmide from Calbiochem, puromycin and iodoacet- 
amide from Aldrich, 3-methyladenine from Fluka and aprotinin from 
Bayer. 
2.2. Antibodies 
mAb DH12 and mAb HP2/1 recognize respectively the /?l and the 
a4 subunits of the VLA mtegrins 1451. A rabbit antiserum (221M) 
against ubiquitm from Biomeda and a mouse anti-ubiquitin mAb 
(mAb 1510) from Chemtcon were used. 
2.3. Cells 
Diploid human skin fibroblasts (NHF) were grown and processed 
as described [2]. 
Molt-4 cells (ATCC) were cultured m DMEF-12 without TES and 
HEPES with l&15% fetal bovine serum (FBS) (Gibco). 
2.4. Metabolrc labeling 
Cell layers were premcubated (30 min) in cysteine-free medium 
(Select Amme-kit. Gibco) and metabolically labeled (30 min) with 0.1 
mCi/ml [“Slcysteine (+I000 Ci/mmol; NEN). Chase was performed in 
culture medium without Ultroser. At the appropriate time the cells 
were washed 3 times with 10 ml Tris buffered saline, pH 7.2, contain- 
ing protease inhibitors (PI) (3 mM EDTA, 1 mM iodoacetamide, 1 
&ml pepstatin and 100 &ml aprotinin), and scraped in this buffer. 
Molt-4 cells were premcubated (45 min) in cysteme-free RPM1 1640 
medium, [35S]cysteine was added at 0.25 mCi/ml for 30 mm. After one 
washing, cells were resuspended in culture medium. At the appropriate 
time, cells were washed with ice-cold Tris-NaCl buffer (Tris-HCl 20 
mM pH 7.4, NaCl 150 mM) containing PI (leupeptin, antipam, pep- 
statm and chymostatin at 1 &ml, SBTI at 20,&ml and 1 mM PMSF) 
and stored at -20°C. Molt-4 buffers, except if otherwise mentioned 
contain 1 mM CaC&/MgCI, to favor a4Bl coprecipitation. 
The cells were lysed in 1 ml ice-cold Dippa buffer (TrislNaCI buffer 
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supplemented with 1% Triton X- 100, 1% DOC and 0.1% SDS and PI), 
then sonicated (15 s) and centrifuged at 17,000 rpm for 30 mm. 
2.5. Inlnlunoprecipltatron und electrophoresrs 
Extracted proteins were precleared at 4°C on aspecific polyclonal 
rabbit anti-mouse IgG (RAM) (Dako) immobilized on Sepharose 4B 
beads, lmmunoprecipitations with mAb DH12 were performed with 
50.~~1 Sepharose 4B beads loaded with 5 mg/ml mAb. For immunopre- 
cipitations with mAb HP2/1, 75 ,LLI of mAb-containing culture super- 
natants were mixed with precleared cell lysates. After 2 h, immune 
complexes were isolated with 50 ~1 Sepharose 4B beads loaded with 
10 mg/ml RAM IgG. The resultmg immunoprecipitates were washed 
5 times with 1 ml ice-cold Dippa buffer, and applied (eventually after 
reduction with 1% B-mercaptoethanol) on SDS-PAGE (6-10%). Gels 
were processed as described [2]. Autoradiograms were scanned usmg 
a Personal Densitometer (Molecular Dynamics). 
2.6. Endoglycoslduse-H treatment 
The antigen loaded immunobeads were digested for 16 h at 37°C 
with 5 mU Endo-H in 50 ~1 of 0.1 M sodium phosphate buffer, pH 
5.5, contaming 100 mM 6-AHA, 32 .&ml leuprptin, 4 pg/ml pep- 
statin, and 200 U/ml aprotinm. 
2.7. Protem sqnthesrs inhlbrtion 
Cells were preincubated 1 h (or 2 h). transferred m cysteine-free 
medium containmg the inhibitor for 45 min and then labeled for 30 
min. After two washings with TrislNaCl buffer containing PI, the cells 
were solubihzed and trichloroacetic acid precipitations done on cell 
extracts, The given percentages are the mean of three measurements 
of TCA precipitable labeled proteins from treated compared to un- 
treated control cells. Table I gives the concentration of the Inhibitor 
and its effect on protem syntheses. 
3. RESULTS AND DISCUSSION 
When NHF were pulse labeled with radioactive cyste- 
ine for 30 min and chased in the presence of cyclo- 
heximide (2Spg/ml), morej?l precursor but less mature 
pl subunit could be precipitated than in the controls. 
The limited amount of endoH resistant j?l subunit also 
showed a longer half-life (Fig. 1, upper panel). 
Molt-4 cells treated under similar conditions and 
chased with cycloheximide (10 pglml) (Fig. 1, lower 
panel) also showed a st ,bilization of the pl precursor, 
Table I 
Compound Concentration % inhibition of protein synthesis** 
NHF Molt-4 
Puromycm 5 @ml 45% 
20 &ml 90% 90% 
50 &ml 92% 
Hygromycin 5 pg/ml 25% 
50 pg/ml 45% 7% 
250 pg/ml 85% 12%* 
500 &ml 20%* 
Cycloheximide 2.5 lug/ml 88% 
5 pg/ml 90% 90% 
10 &ml 92% 92% 
*2 h preincubation Instead of 1 h. 
**Each value represents the mean of one experiment done in triplicate. 
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but maturation was apparently unaffected. The mature 
form was much more stable during the cycloheximide- 
chase than in controls. Cycloheximide preparations 
from 3 different commercial sources had similar effects. 
Protein synthesis was substantially inhibited (90%). 
after 1 h preincubation with 20 pug/ml puromycin (Table 
I). 
When puromycin was added to the NHF chase me- 
dium (Fig. 2, upper panel) the degradation of the pl 
precursor was also significantly decreased. Almost no 
mature pl subunit was immunoprecipitated. 
In the Molt-4 cells (Fig. 2, lower panel) a similar 
effect was observed but, in contrast to cycloheximide (5 
,&ml) which seemed to stabilize the mature or4/31 com- 
plex, puromycin (20 ,q$ml) did not increase the half-life 
of the endo- H resistant heterodimer. To ensure that the 
activity of puromycin was not decreased after several 
hours of chase, an additional 20 ,ug/ml puromycin was 
added to the chase medium after 7 h, without additional 
effect, however. on the half-life of the mature a4pl (data 
not shown). 
Hygromycin B (250 pglml) treatment of NHF gave 
results similar to puromycin (data not shown). Molt-4 
cells were not tested since hygromycin B inhibited pro- 
tein synthesis in these cells by only 20% (Table I). 
Our results suggest a double effect of cycloheximide 
on j?l degradation; it interferes with the rapid degrada- 
tion of the /?l precursor and with the slow disappear- 
ance of the endo-H resistant mature form. At both lev- 
els, in presumably different compartments, cyclo- 
heximide seems to stabilize the /31 subunit. Possibly, the 
synthesis of a labile factor, which tags these glycopro- 
teins for degradation. or of unstable proteinases, char- 
acterized by short half-lives, is affected by these com- 
pounds. 
While puromycin is thought to be a more potent pro- 
tein synthesis inhibitor than cycloheximide. puromycin 
was unable to increase the half-life of the mature pl 
subunit. 
In addition to their different mechanisms of protein 
synthesis inhibition during translation, differential ef- 
fects of puromycin and cycloheximide have only been 
documented at the transcriptional level; for instance of 
the metallothionein (MT) gene [6]. Similar findings to 
the ones described here have, however, not been docu- 
mented. 
Differences were also observed between both cell sys- 
tems regarding the amount of mature /U immunopre- 
cipitated. Indeed, the amount of mature subunit im- 
munoprecipitated from NHF was significantly reduced, 
in comparison with the control, while no significant 
alteration in the maturation process was observed in 
Molt-4. 
An explanation for this observation would be that 
differences in the maturation pathways or in the vesicu- 
lar transport do exist between both cell lines or that 
protein synthesis inhibition interferes with a mannosi- 
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Fig. 1. (Upper panel) Effect of cycloheximide on the degradation of the /_I1 precursor in NHF. NHF cells were pulse labeled for 30 min with 
[%]cysteme and chased in complete medium for different times in the absence or presence of ~ycIohex~ide (2.5 ,@mt). Cell &sates were 
immunoprecipitated with mAb DHl2 and analyzed by SDS-PAGE after endo-H treatment. Bl pre is the precursor,,61 is the mature form (Lower 
panel) Effect of cycloheximide on the synthesis and degradatron of the a4;81 complex. Molt-4 cells were pulse labeled for 30 min with [‘%]cysteine 
and chased in the presence or absence of 10 pg/rnl cycloheximrde for the indicated trme periods. Cell lysates were immunoprecipitated with mAb 
DH12 and analyzed by SDS-PAGE under reducing conditions. 
dase or transferase specifically involved in the trimming 
of oligosaccharides in NHF. Such effects on fibroblasts 
were nevertheless never reported previously. 
Biosynthetic studies of B-N-acetyl-p-hexosaminidase 
A in fibroblast, have shown that cycloheximide inhib- 
ited the association and subsequent maturation of pre- 
formed a-chains by inducing a depletion of the P-chain 
precursor pool upstream from the site of a/? association 
[7]. If cycloheximide induced a depletion of the a-chain 
precursor pool, unassociated pl integrin subunit would 
be unable to translocate out of the ER. Since the CX/@ 
precursor ratio in Molt-4 is higher than in fibroblasts, 
quantitative differences between ct pools in both ceil 
systems could be responsible for the difference in the 
proportion of mature @l observed. 
The mature /-II subunit has a half-life of about 6 to 
8 hours in Molt-4 (Fig. 3), and about 8 h in NHF [2]. 
Addition of a mixture of ATP synthesis inhibitors 
(NaF 5 mM/lO mM and NaN, 20 mM/40 mM) 7 h after 
the beginning of the chase partially blocked the degra- 
dation of the mature a4/31 dimer (between 15-30% in 
different quantitated experiments). Moreover, addition 
of 5 mM NaF and 20 mM NaN, at the beginning of the 
chase stabilized the PI precursor during, at least, the 
first 3 h of the chase (Fig. 4). These effects of cyclo- 
heximide and ATP depletion on the p 1 precursor resem- 
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Fig. 2. (A) Effect of puromycin on the degradation of the fil precursor m NHF. NHF cells were pulse labeled for 30 min with [“Sjcysteine and 
chased in complete medium for different times in the absence or presence of different concentrations of puromycm. Cell lysates were tmmunopre- 
cipitated with mAb DH12 and analyzed by SDS-PAGE after endo-H treatment. (B) Effect of puromycin on the synthesis and degradation of the 
/?I subumt m Molt-4. Molt-4 cells were pulse labeled for 30 min with [?‘S]cysteine and chased in the presence or absence of 20 &ml puromycin 
for the mdicated time periods. As control. cells chased in the presence of cycloheximide (5 pglml) are also shown. Cell lysates were immunopr~clp- 
ttated with mAb DHI:! and analyzed by SDS-PAGE under reducing condittons. 
ble the stabilization observed under similar conditions 
of the 35 kDa intermediate fragment of unassembled 
H2a of the human asialoglycoprotein receptor in 3T3 
fibroblast [S]. 
Addition of NH&I or a thiol protease inhibitor (le- 
upeptin) to the chase medium after 8 h of chase did not 
increase the half-life of the receptor suggesting that lyso- 
somes or endocytosis were not involved in this degrada- 
tion (Fig. 5) (for a review see 191). 
Recent evidence suggests that cell surface glycopro- 
teins, such as the 90 kDa lymphocyte homing receptor 
recognized by MEL-14, can also be ubiquitinated 
[ 10,l I]. Cell lysates of Molt-4 showed different ubiquiti- 
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nated proteins on Western blotting, but immunoprecip- 
itates of j?l integrins with mAb DH12 did not reveal 
ubiquitinated forms of integrins. Moreover, 3-methy- 
ladenine, a specific inhibitor of autophagic protein deg- 
radation [12] had no effect on the stability of either the 
precursor or the mature ,f?l subunit (data not shown). 
These results suggest hat the half-life of the VLA-4 
receptor in Molt-4 is not dependent on classic lysosomal 
or ubiquitination degradation pathways. 
An alternative to intracellular degradation would be 
that /?i receptors disappear from the cell surface by 
shedding of entire membrane fragments (exosomes) as 
is the case for the transferrin receptor and MHCE-II 
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Fig. 3. Turn-over of VLA-4 on Molt-4. Molt-4 cells were pulse labeled for 30 mm with [?S]cysteine and chased for the indicated time periods. Cell 
lysates were immunoprecipitated with mAb DH12 and analyzed by SDS-PAGE under reducing conditions. Autoradiogram (a) was densttometri- 
tally scanned (b). 
antigens, or by proteolytic degradation at the cell sur- 
face as is probably the case of the MEL-14 antigen 
which can be recovered from the medium as a 5-l 0 kDa 
shorter form upon addition of low doses of chymostatin 
[13,14]. In CHO cells, shedding of VLA-5 into the me- 
dium upon binding with a specific mAb was reported 
by Sczekan and Juliano [ 151. Cycloheximide then could 
act on the shedding or on receptor proteolysis. 
A last possibility would be that the transport of ma- 
ture endo-H resistant a4Bl complex from the trans- 
-200 
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4 NaF 5 mM NaN, 20 mM Control after 7 hr of chase 
Fig. 4. Effect of ATP depletion on the degradation of rx4pl. Molt-4 cells were pulse labeled for 30 min with [35S]cysteine and chased for the indicated 
time periods in the presence or absence of NaF (5 mM) and NaN, (20 mM).The 2 last lanes show samples chased 7 h before addition of (NaF 
5 mM + NaN, 20 mM) (24’) or (NaF 10 mM + NaN, 40 mM) (24”). Cell lysates were immunoprecipitated with mAb DH12 and analyzed by 
SDS-PAGE under reducing conditions. 
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Fig. 5. Effect of lysosomal inhibitors on the degradation of the mature /I1 subunit. Molt-4 cells were pulse labeled for 30 min with [“Slcysteine 
and chased for 1 or 8 h. After 8 h of chase, cell ahquots were treated with lysosomal inhibitors (control without) and further chased up to 24 h. 
Cell lysates were tmmunoprecipitated with mAb DH12 in the presence of 5 mM EDTA in order to look only at thebl subumt. Half of each sample 
was submttted to endo-H digestion and samples were analyzed by SDS-PAGE under reducing conditions. 
Golgi to the surface is affected by cycloheximide. and 
that the complex is thereby stabilized. 
Finally, since cycloheximide caused decreased copre- 
cipitation of ~14 and pl in Molt-4 cells a conformational 
change affecting their association cannot be excluded. 
Such a change could be due to an altered glycosylation 
(sialylation) for instance. It is interesting to note that 
treatment with cycloheximide abolished the adhesion 
of lymphoid cell lines to the heparin binding domain 
fragments of fibronectin [16]. How this observation 
relates to the ones described here remains to be deter- 
mined. 
In conclusion, the metabolism of VLA integrins 
seems to have a number of unusual properties, such as 
massive pre-Golgi degradation of the /31 precursor, sen- 
sitivity to protease inhibitors and to energy depletion, 
turn-over at the cell surface, which may be extremely 
important in the regulation of their expression and func- 
tion. 
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